BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15061568)

  • 1. Cytokines in the rheumatic diseases.
    Arend WP; Gabay C
    Rheum Dis Clin North Am; 2004 Feb; 30(1):41-67, v-vi. PubMed ID: 15061568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cytokines and cell response in surgery.
    Lin E; Calvano SE; Lowry SF
    Surgery; 2000 Feb; 127(2):117-26. PubMed ID: 10686974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines in the nervous system: multifunctional mediators in autoimmunity and cerebral ischemia.
    Stoll G
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):887-91. PubMed ID: 12407295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mechanisms in rheumatic disease.
    Workman ML
    Nurs Clin North Am; 2000 Mar; 35(1):175-88. PubMed ID: 10673573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and inflammatory mediators in cystic fibrosis.
    Courtney JM; Ennis M; Elborn JS
    J Cyst Fibros; 2004 Dec; 3(4):223-31. PubMed ID: 15698939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
    Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
    Life Sci; 2007 Oct; 81(19-20):1403-10. PubMed ID: 17950363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being.
    Elenkov IJ
    Neurochem Int; 2008 Jan; 52(1-2):40-51. PubMed ID: 17716784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.
    Ben-Baruch A
    Semin Cancer Biol; 2006 Feb; 16(1):38-52. PubMed ID: 16139507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1.
    Blandino-Rosano M; Perez-Arana G; Mellado-Gil JM; Segundo C; Aguilar-Diosdado M
    J Mol Endocrinol; 2008 Jul; 41(1):35-44. PubMed ID: 18487229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrition and pediatric rheumatic diseases. Hypothesis: cytokines modulate nutritional abnormalities in rheumatic diseases.
    Ostrov BE
    J Rheumatol Suppl; 1992 Apr; 33():49-53. PubMed ID: 1593602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches.
    Gullestad L; Aukrust P
    Am J Cardiol; 2005 Jun; 95(11A):17C-23C; discussion 38C-40C. PubMed ID: 15925560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catecholamine cytokine balance: interaction between the brain and the immune system.
    Szelényi J; Vizi ES
    Ann N Y Acad Sci; 2007 Oct; 1113():311-24. PubMed ID: 17584982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in rheumatic diseases.
    Miller LC
    Biotherapy; 1994; 8(2):99-111. PubMed ID: 8924358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibility of formation of the S100A8/A9-proinflammatory cytokine complexes in vivo in acute inflammation and their functional roles].
    Ishihara K; Namura T; Murayama H; Arai S; Totani M; Ikemoto M
    Rinsho Byori; 2009 Apr; 57(4):324-31. PubMed ID: 19489433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New cytokine targets in inflammatory rheumatic diseases.
    Connell L; McInnes IB
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):865-78. PubMed ID: 16980211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proinflammatory cytokines in cardiovascular diseases as potential therapeutic target].
    Bielecka-Dabrowa A; Wierzbicka M; Goch JH
    Wiad Lek; 2007; 60(9-10):433-8. PubMed ID: 18350717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of inflammatory cytokines cause a spectrum of chronic progressive diseases: implications for therapy.
    Forrester JS; Bick-Forrester J
    Med Hypotheses; 2005; 65(2):227-31. PubMed ID: 15922092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of inflammatory cytokines by omega-3 fatty acids.
    Kang JX; Weylandt KH
    Subcell Biochem; 2008; 49():133-43. PubMed ID: 18751910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases.
    Calcagni E; Elenkov I
    Ann N Y Acad Sci; 2006 Jun; 1069():62-76. PubMed ID: 16855135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.